Bioceres Crop Solutions Corp. logo

Bioceres Crop Solutions Corp.

BIOX

NASDAQBasic MaterialsAgricultural Inputs

常规交易时段

US$0.4279

−US$0.013 · -2.95%

8月24日 10:15 ET延迟

BIOX公司概览

盘中时间采用ET。市场数据可能有所延迟。

GoAI 研究快照

简明呈现最新可用的模型信息。

2026年7月10日

GoAI评分

Sell

Trim exposure — unfavorable risk-reward

估值

47

Fair Value

动量

19

Strong Down

情绪

40

Bearish

风险韧性

34

High Risk

完整 GoAI 研究

继续查看更深入的依据、催化因素和风险。

查看完整研究

人工智能生成的上下文仅供参考,并非投资建议。

公司概况

公司网站

Bioceres Crop Solutions Corp. (BIOX) is a company dedicated to enhancing agricultural output through a diverse range of solutions. Its operations are organized into three principal divisions. The Seed and Integrated Products segment is responsible for creating and bringing to market cutting-edge seed technologies, genetic material, biotechnological innovations, and specialized seed coatings. Under its Crop Protection segment, the company formulates, manufactures, and distributes a comprehensive array of products, including Rizoderma, various adjuvants, therapeutic agents, weed killers, insect eradicators, fungal treatments, and pest lures. The Crop Nutrition unit focuses on the development, production, and distribution of inoculants, bio-stimulants, and both organic and micro-granular fertilizers. A notable offering from Bioceres is HB4, an innovative seed technology engineered for drought resistance. The enterprise maintains a significant presence across several countries, including Argentina, Uruguay, France, and South Africa, alongside broader international operations. Established in 2001, the firm's main offices are situated in Rosario, Argentina. Bioceres Crop Solutions Corp. functions as a subsidiary entity under the umbrella of Bioceres LLC.

行业
Agricultural Inputs
部门
Basic Materials
总部
AR
首席执行官
Federico Trucco
上市以来
2018年3月22日
雇员
751

市场位置

日内区间

当前US$0.4279,

52周区间

当前US$0.4279,

开盘价
US$0.44
前收盘价
US$0.4409
成交量
2.3万
0.09× 平均值
平均成交量
24.74万
日均成交量
市值
2705.53万 USD
贝塔
0.4
市场参考 1
50天平均值
US$0.3669
高于平均水平+16.63%
200天平均值
US$0.7566
低于平均水平-43.45%

财务数据

财务快照

最近十二个月

估值与收益率

企业价值
5.26亿 USD
EV/EBITDA
-53.94×
盈利收益率
-19.62%
自由现金流收益率
12.49%

盈利能力和效率

净资产收益率
-21.09%
资产收益率
-7.26%
投入资本回报率
-0.12%

财务健康

流动比率
0.91×

分析师评级

第三方分析师预期可能变化,并非 GoAI 建议。

评级分布

5项评级
强力买入00%
买入480%
持有120%
卖出00%
强力卖出00%

BIOX同业公司

持有BIOX的ETF

报告持有此股票敞口的交易所交易基金。

继续GoAI的研究

在 GoAI 中研究BIOX

research.disclaimer